The steady growth of Medicare Advantage (MA) plans, a cornerstone of healthcare for millions of seniors and individuals with disabilities, is demonstrably slowing. New data reveals a deceleration in enrollment, coupled with a strategic retreat by major health insurance companies, signaling a shift in the landscape of this increasingly important segment of the US healthcare system. This slowdown isn’t simply a leveling off; it reflects a complex interplay of factors, including shrinking profits, regulatory scrutiny, and evolving market dynamics.
As of February 2026, approximately 35.5 million people are enrolled in Medicare Advantage plans, representing a growth of around 3% compared to the 34.4 million enrolled in the same period last year, according to recently released government data. Even as still positive, this growth rate pales in comparison to the historically rapid expansion of MA, which at times reached as high as 10% annually. This deceleration is prompting insurers to reassess their involvement in the program, leading to market exits and plan redesigns aimed at managing profitability.
The shift is particularly noticeable among industry giants. UnitedHealthcare, the largest Medicare Advantage carrier, saw a 9% decrease in enrollment between October and February, falling just shy of 9.4 million members. Similarly, Elevance, Centene, and CVS Health (through its Aetna division) experienced membership declines of 14%, 4%, and 3%, respectively. These reductions aren’t accidental; they represent deliberate strategies to shed less profitable members and streamline operations. The changing dynamics within Medicare Advantage are raising questions about the long-term sustainability of the program’s rapid growth and the role of private insurers in delivering Medicare benefits.
Medicare Advantage Enrollment Slowdown: A Sign of Shifting Tides
The deceleration of Medicare Advantage growth isn’t a sudden phenomenon. Insurers have been signaling their concerns for some time, citing unfavorable regulatory changes and rising medical costs as key drivers. The Centers for Medicare & Medicaid Services (CMS) has been increasingly focused on ensuring the accuracy of risk scores – a crucial element in determining how much federal funding MA plans receive – and has implemented stricter auditing procedures. These changes, while intended to improve program integrity, have put pressure on insurer margins.
A recent analysis of CMS data highlights the extent to which insurers are “pumping the brakes” on their MA businesses for 2026. This includes exiting certain markets and adjusting plan designs to discourage enrollment from individuals with higher healthcare needs, who tend to be more costly to cover. The strategy reflects a growing emphasis on profitability over sheer enrollment numbers, a trend that has sparked debate among policymakers and healthcare advocates. The focus on financial performance raises concerns about potential limitations in access to care and the quality of services provided to beneficiaries.
Humana Stands Apart, But at a Cost
While most major insurers are scaling back their Medicare Advantage offerings, Humana is bucking the trend. The company has actively expanded its presence in the program, adding over 1 million members since the start of open enrollment, bringing its total enrollment to over 7 million as of February. This aggressive expansion could potentially position Humana to surpass UnitedHealthcare as the largest MA insurer. Although, this growth comes at a price. Humana anticipates adjusted earnings per share of $9 for the year, a significant decrease from analysts’ expectations and roughly half of its 2025 earnings. This suggests that Humana is willing to sacrifice short-term profits to gain market share, a gamble that could pay off if the company can effectively manage costs and maintain quality of care.
Kaiser Permanente, a major nonprofit healthcare provider, likewise experienced modest enrollment growth, increasing its MA membership by 1% to approximately 2 million. Several smaller players, including Devoted Health, Alignment Health, The SCAN Group, Aware Integrated, Medica Holding Company, and CareSource, have also capitalized on the shifting landscape, attracting new members and gaining market share. These smaller insurers often focus on specific geographic areas or niche markets, allowing them to offer tailored plans and personalized services.
Regulatory Scrutiny and the Future of Medicare Advantage
The slowdown in Medicare Advantage growth coincides with increased scrutiny of the program’s financial practices. Concerns have been raised about overpayments to insurers, stemming from incentives to exaggerate the health needs of their members. The Medicare Payment Advisory Commission (MedPAC) has estimated that Medicare Advantage plans received approximately $76 billion in overpayments in 2026, highlighting the demand for greater oversight and accountability. MedPAC’s report underscores the financial implications of these overpayments and the potential for reform.
concerns have been voiced regarding the use of algorithms and restrictive provider networks by some MA plans, which can limit access to care for beneficiaries. These issues have fueled calls for MA reform and stricter regulation from federal authorities. Interestingly, officials within the Trump administration have shown an unexpected willingness to address these concerns, pursuing tighter risk adjustment standards and reviving more aggressive audits of plan payments. This shift in regulatory posture suggests a potential course correction for the program, aimed at ensuring its long-term sustainability and protecting the interests of beneficiaries.
The proposed rate structure for 2027, which suggests keeping payment rates flat, has drawn criticism from the insurance industry, who argue that a generous payment increase is necessary to account for rising medical expenses. However, some experts contend that MA margins remain healthy for many insurers and that the proposed rate represents a necessary adjustment after years of overly generous funding. The debate over payment rates is likely to continue, shaping the future of Medicare Advantage and its role in the US healthcare system.
Impact on Beneficiaries and the Road Ahead
The changes within Medicare Advantage have direct implications for the over 35 million beneficiaries enrolled in these plans. While the slowdown in growth doesn’t necessarily mean fewer options, it could lead to more selective enrollment practices and potentially higher premiums for some individuals. Beneficiaries should carefully evaluate their options during open enrollment periods and consider factors such as provider networks, coverage benefits, and out-of-pocket costs. It’s crucial to understand the specific terms of each plan and choose the option that best meets their individual healthcare needs.
The turbulence experienced during the 2026 Medicare enrollment period, with millions of seniors switching plans due to insurer exits, suggests that 2027 could be equally challenging. The future of Medicare Advantage will likely depend on the outcome of ongoing policy debates and the ability of insurers to adapt to a changing regulatory landscape. The proposed flat payment rates for 2027, if implemented, could further exacerbate the challenges facing MA plans, potentially leading to additional market consolidation and reduced benefits. The coming months will be critical in determining the long-term trajectory of this vital healthcare program.
Key Takeaways:
- Medicare Advantage growth is slowing significantly, with enrollment increasing by only 3% in February 2026.
- Major insurers like UnitedHealthcare, Elevance, and CVS Health are reducing their MA footprints, while Humana is expanding.
- Increased regulatory scrutiny and concerns about overpayments are driving changes in the program.
- Beneficiaries should carefully evaluate their options and understand the terms of their MA plans.
- The future of Medicare Advantage hinges on ongoing policy debates and the ability of insurers to adapt to a changing landscape.
The next key development to watch will be the finalization of the 2027 Medicare Advantage payment rates by CMS, expected in the coming months. This decision will have a profound impact on the program’s future and the strategies employed by insurers. We encourage readers to share their thoughts and experiences with Medicare Advantage in the comments below.
Worth a look